ZENITHDRUG logo

Zenith Drugs NSEI:ZENITHDRUG Stock Report

Last Price

₹63.25

Market Cap

₹1.1b

7D

-1.7%

1Y

n/a

Updated

11 Jul, 2024

Data

Company Financials

Zenith Drugs Limited

NSEI:ZENITHDRUG Stock Report

Market Cap: ₹1.1b

ZENITHDRUG Stock Overview

Operates as a pharmaceutical manufacturing and trading company in India and internationally.

ZENITHDRUG fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends2/6

Zenith Drugs Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zenith Drugs
Historical stock prices
Current Share Price₹63.25
52 Week High₹114.50
52 Week Low₹52.80
Beta0
11 Month Change-2.17%
3 Month Change-1.02%
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-39.85%

Recent News & Updates

Recent updates

Shareholder Returns

ZENITHDRUGIN PharmaceuticalsIN Market
7D-1.7%3.6%1.0%
1Yn/a51.4%45.3%

Return vs Industry: Insufficient data to determine how ZENITHDRUG performed against the Indian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how ZENITHDRUG performed against the Indian Market.

Price Volatility

Is ZENITHDRUG's price volatile compared to industry and market?
ZENITHDRUG volatility
ZENITHDRUG Average Weekly Movement7.3%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: ZENITHDRUG has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ZENITHDRUG's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200061Sandeep Bhardwajzenithdrugs.com

Zenith Drugs Limited operates as a pharmaceutical manufacturing and trading company in India and internationally. The company offers products in the areas of electrolytes, analgesic, antipyretic, NSAIDs, anti-inflammatory, antiemetic, cold, cough, antihistaminic and antiasthmatic, antibacterial, antifungal, anti-infective, antiparasitic, antiviral, anthelmintic, anti-scabies, antimicrobial, antimalarial, disinfectant, antiseptic, corticosteroids, depigmenting agents, gastrointestinal, liver, kidney, skin care, antibiotic preparations, nutrition supplements, and others. It also provides a range of formulations in various forms, such as ORS powder, liquid orals, ointments, creams, gels, tablets, liquid externals, and capsules.

Zenith Drugs Limited Fundamentals Summary

How do Zenith Drugs's earnings and revenue compare to its market cap?
ZENITHDRUG fundamental statistics
Market cap₹1.08b
Earnings (TTM)₹95.93m
Revenue (TTM)₹1.32b

11.3x

P/E Ratio

0.8x

P/S Ratio

Is ZENITHDRUG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZENITHDRUG income statement (TTM)
Revenue₹1.32b
Cost of Revenue₹855.07m
Gross Profit₹461.12m
Other Expenses₹365.20m
Earnings₹95.93m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.59
Gross Margin35.03%
Net Profit Margin7.29%
Debt/Equity Ratio39.5%

How did ZENITHDRUG perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

7%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.